We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

136 hedge funds and large institutions have $531M invested in VanEck Pharmaceutical ETF in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $516M → $531M (+$15M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 142 → 136 (-6)

9.6% less ownership

Funds ownership: 87.95% → 78.35% (-9.6%)

20% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 25

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

97% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $64.7M

Holders
136
Holders Change
-6
Holders Change %
-4.23%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
20
Increased
36
Reduced
50
Closed
25
Calls
$1.67M
Puts
$64.7M
Net Calls
-$63.1M
Net Calls Change
-$59.9M

Top Buyers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
+$115M
2
UBS Group
UBS Group
Switzerland
+$18.5M
3
QC
Quadrature Capital
United Kingdom
+$11.5M
4
Bank of America
Bank of America
North Carolina
+$6.2M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$102M
2
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
-$17.3M
3
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$13.2M
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$11.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$8.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
AT
126
Arlington Trust
Alabama
$7.75K +$7.66K +85 New
BBPWM
127
Blue Bell Private Wealth Management
Pennsylvania
$7.11K – – –
AWM
128
Activest Wealth Management
Florida
$6.74K -$26.9K -299 -80%
AssetMark Inc
129
AssetMark Inc
California
$6.11K -$83.9K -932 -93%
S
130
SignatureFD
Georgia
$5.92K – – –
AIM
131
Anchor Investment Management
South Carolina
$5.29K – – –
SWA
132
SOA Wealth Advisors
New York
$3.16K – – –
Barclays
133
Barclays
United Kingdom
$1.82K – – –
MSWM
134
Mowery & Schoenfeld Wealth Management
Illinois
$1.15K +$1.17K +13 New
TRCT
135
Tower Research Capital (TRC)
New York
$911 -$3.11M -34,541 -100%
GFPC
136
Global Financial Private Client
Florida
$91 – – –
HNB
137
Huntington National Bank
Ohio
$78 – – –
Wells Fargo
138
Wells Fargo
California
$33 -$22.7K -252 Closed
MTWSIF
139
Mivtachim The Workers Social Insurance Fund
Israel
– -$17.3M -200,000 Closed
Thrivent Financial for Lutherans
140
Thrivent Financial for Lutherans
Minnesota
– -$13.2M -153,063 Closed
AWM
141
Apollon Wealth Management
South Carolina
– -$2.82M -32,708 Closed
BCP
142
Blue Chip Partners
Michigan
– -$2.14M -24,786 Closed
Marshall Wace
143
Marshall Wace
United Kingdom
– -$1.23M -14,232 Closed
SPC
144
Spirepoint Private Client
Florida
– -$1.02M -11,840 Closed
SOS
145
Silver Oak Securities
Tennessee
– -$742K -8,626 Closed
LSA
146
Lansing Street Advisors
Pennsylvania
– -$516K -5,978 Closed
Millennium Management
147
Millennium Management
New York
– -$491K -5,685 Closed
PAG
148
Private Advisory Group
Washington
– -$487K -5,648 Closed
IMC
149
Investment Management Corporation
Virginia
– -$458K -5,307 Closed
D.E. Shaw & Co
150
D.E. Shaw & Co
New York
– -$339K -3,933 Closed
3 4 5
6
7

PPH Hedge Fund Activity: Q1 2025 in Review

136 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q1 2025, worth a combined $531M — up 2.9% from $516M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of PPH and 20 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 36 added.

The largest buyer was Fisher Asset Management, opening a new position worth an estimated $115M. The largest seller was Goldman Sachs, cutting an estimated $102M.

  • 136 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q1 2025, down from 142 in Q4 2024.
  • Funds reported $531M of VanEck Pharmaceutical ETF stock for Q1 2025, up 2.9% quarter-over-quarter.
  • 20 funds opened new VanEck Pharmaceutical ETF positions in Q1 2025 and 25 closed out, a net change of -5 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q1 2025 was Fisher Asset Management, an estimated $115M added.
  • The largest VanEck Pharmaceutical ETF seller in Q1 2025 was Goldman Sachs, an estimated $102M sold.

Based on aggregated 13F filings for Q1 2025.